Biotechnology
2025Fiscal year
Companies 53
Median of average pay per registered director · KRW 204 million
| Company | Notes | ||||
|---|---|---|---|---|---|
| Rznomics | KRW 193 million | KRW 221 million | 6 | 39 | Denominator mismatch flagged |
| D&D Pharmatech | KRW 169 million | KRW 260 million | 3 | 22 | |
| Alteogen | KRW 149 million | KRW 862 million | 4 | 161 | |
| GI Innovation | KRW 143 million | KRW 555 million | 4 | 42 | Denominator mismatch flagged |
| ABL Bio | KRW 124 million | KRW 1,094 million | 2 | 108 | |
| Celestra | KRW 86 million | KRW 126 million | 3 | 11 | |
| Tool Gen | KRW 85 million | KRW 188 million | 6 | 66 | |
| Genexine | KRW 83 million | KRW 215 million | 3 | 68 | |
| Proteina | KRW 79 million | KRW 110 million | 7 | 28 | Filer note attached |
| NH Nongwoobio | KRW 77 million | KRW 89 million | 5 | 378 | |
| Hugel | KRW 74 million | KRW 2,155 million | 4 | 336 | |
| Geninus | KRW 72 million | KRW 100 million | 1 | 59 | |
| Gene One Life Science | KRW 71 million | KRW 40 million | 3 | 52 | Filer note attached |
| Medipost | KRW 68 million | KRW 339 million | 4 | 145 | Denominator mismatch flagged |
| Xcell Therapeutics | KRW 67 million | KRW 174 million | 3 | 65 | |
| Quratis | KRW 66 million | KRW 31 million | 4 | 26 | Denominator mismatch flagged |
| Medy-Tox | KRW 64 million | KRW 391 million | 3 | 753 | |
| Pangen Biotech | KRW 63 million | KRW 46 million | 7 | 41 | |
| Aimed Bio | KRW 63 million | KRW 226 million | 3 | 52 | |
| Pharos I-Bio | KRW 62 million | KRW 212 million | 3 | 33 | |
| Bio Solution | KRW 61 million | KRW 245 million | 3 | 54 | |
| Seou Lin Bioscience | KRW 61 million | KRW 421 million | 4 | 110 | |
| Eu Biologics | KRW 61 million | KRW 391 million | 6 | 397 | |
| Y-Biologics | KRW 60 million | KRW 294 million | 3 | 58 | |
| Celemics | KRW 60 million | KRW 220 million | 3 | 41 | |
| Poongjeon Pharmacy | KRW 59 million | KRW 69 million | 4 | 25 | Filer note attached |
| Peptron | KRW 59 million | KRW 397 million | 3 | 160 | Filer note attached |
| Eyegene | KRW 59 million | KRW 127 million | 4 | 49 | |
| Ab Clon | KRW 58 million | KRW 204 million | 3 | 66 | |
| HLB Genex | KRW 57 million | KRW 110 million | 5 | 82 | |
| Kangstem Biotech | KRW 57 million | KRW 165 million | 4 | 86 | |
| Bio-FD&C | KRW 56 million | KRW 236 million | 3 | 78 | |
| Eutilex | KRW 55 million | KRW 233 million | 3 | 119 | |
| Cellid | KRW 55 million | KRW 153 million | 3 | 24 | Filer note attached · Denominator mismatch flagged |
| Curocell | KRW 55 million | KRW 257 million | 3 | 146 | |
| Helixmith | KRW 54 million | KRW 182 million | 5 | 44 | |
| T&R Biofab | KRW 54 million | KRW 163 million | 4 | 52 | |
| Bioneer | KRW 52 million | KRW 369 million | 5 | 362 | |
| Sun Bio | KRW 52 million | KRW 100 million | 3 | 29 | Denominator mismatch flagged |
| Quad Medicine | KRW 51 million | KRW 119 million | 3 | 90 | |
| Amicogen | KRW 50 million | KRW 146 million | 4 | 228 | |
| S.Biomedics | KRW 49 million | KRW 110 million | 5 | 52 | |
| Tego Science | KRW 48 million | KRW 315 million | 3 | 40 | |
| CorestemChemon | KRW 48 million | KRW 125 million | 4 | 321 | |
| Organoid Sciences | KRW 48 million | KRW 112 million | 6 | 89 | |
| Cell Biotech | KRW 46 million | KRW 241 million | 5 | 123 | |
| Genematrix | KRW 45 million | KRW 360 million | 3 | 69 | |
| NatureCell | KRW 45 million | KRW 83 million | 6 | 83 | |
| 아시아종묘 | KRW 40 million | KRW 225 million | 2 | 167 | Fiscal year end 09 |
| GFC Life Science | KRW 38 million | KRW 185 million | 3 | 86 | |
| HLB Pep | KRW 35 million | KRW 83 million | 8 | 88 | Denominator mismatch flagged |
| Orient Bio | KRW 33 million | KRW 230 million | 3 | 123 | Fiscal year end 03 |
| Asia Seed | KRW 11 million | KRW 55 million | 2 | 167 | |
| Kolon Tissue Gene | Foreign-incorporated listing | Foreign-incorporated listing | 3 | 58 | Filer note attached |
Before reading this table
- Figures collect the filed per-person averages without transformation, and can differ from totals divided by headcounts.
- Listed filers only, and consolidated subsidiaries' staff are not included.
- These are filed values whose accuracy the source institution does not guarantee.
- Company rows reproduce each filer's own reported values without transformation, and this site computes none of them.
- Where few registered directors are covered, the per-person average approaches a few individuals' pay.
- Sharing an industry code does not mean doing the same work.
- Filed values on the wrong digit scale are converted to a common basis against the company's own filings in other years, and where no basis exists the reason shows instead of an amount.
- Classifications with thin samples publish no median or weighted industry figure, while the employee average is shown regardless of sample size alongside the company count.
Industry groupings and names follow Naver Finance's sector classification. The per-company figures themselves reproduce annual-report filings.